The chemical class designated as S100A2 Inhibitors encompasses a range of compounds that interact with the S100A2 protein, a member of the S100 family known for its involvement in various cellular processes. These inhibitors are not limited to a single chemical family but are characterized by their ability to influence the activity of S100A2 through different mechanisms. The primary focus of these inhibitors is to modulate the functional aspects of S100A2, which includes its role in calcium binding, gene expression modulation, and interaction with other cellular components. One of the key strategies employed by these inhibitors is targeting the calcium-binding ability of S100A2. Since the activity of S100A2 is significantly influenced by its capacity to bind calcium, compounds that can chelate calcium or alter calcium signaling can effectively modify the function of S100A2. This approach involves compounds that can sequester calcium ions or interfere with calcium channels, thereby affecting the conformation and activity of S100A2. Another significant approach involves influencing the gene expression pathways that regulate S100A2 or are regulated by it. This method includes compounds that act as modulators of gene expression, such as histone deacetylase inhibitors, which alter the chromatin structure and consequently impact the transcription of genes, including those related to S100A2.
Additionally, the interaction of S100A2 with other cellular proteins presents another avenue for inhibition. Compounds that can disrupt these protein-protein interactions can indirectly affect the function of S100A2. This method is particularly relevant in the context of S100A2's involvement in cell proliferation and apoptosis, where its interaction with key regulatory proteins plays a crucial role. Furthermore, the involvement of S100A2 in various signaling pathways, especially those related to cell growth and survival, provides a target for compounds that can modulate these pathways. Inhibitors in this class are capable of affecting these pathways, thereby influencing the activity of S100A2 indirectly. In summary, the class of S100A2 inhibitors is characterized by a diverse range of compounds that can modulate the activity of S100A2 through different mechanisms. These include altering calcium signaling, modulating gene expression, disrupting protein-protein interactions, and influencing various cellular pathways. Each of these methods contributes to the regulation of S100A2's function, emphasizing the multifaceted nature of these inhibitors. As research progresses, the understanding of these interactions and the development of new compounds continue to evolve, enhancing the ability to modulate S100A2's activity in various cellular contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Could possibly inhibit S100A2 by disrupting its calcium-dependent conformational changes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Could possibly inhibit S100A2 by altering gene expression patterns affecting S100A2 or its pathways. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Could possibly inhibit S100A2 by influencing DNA damage pathways where S100A2 is involved. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Could possibly inhibit S100A2 by affecting cell proliferation, a process where S100A2 plays a role. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Could possibly inhibit S100A2 by disrupting cell division, impacting its role in cell growth. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Could possibly inhibit S100A2 by influencing signaling pathways related to its role in inflammation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Could possibly inhibit S100A2 by impacting cellular growth pathways, intersecting with its functions. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Could possibly inhibit S100A2 by affecting its calcium-dependent functions. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Could possibly inhibit S100A2 by influencing its activity in bone-related pathways. | ||||||
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Could possibly inhibit S100A2 by affecting pathways involving S100A2, especially in inflammation. | ||||||